Glucagon-like-1 receptor agonists and sodium/glucose cotransporter-2 inhibitors combination—are we exploiting their full potential in a real life setting?

BACKGROUND: The sodium/glucose cotransporter-2 inhibitors (SGLT-2i) and glucagon-like-1 receptor agonists (GLP-1RA) are antidiabetic agents effective both in hemoglobin A1c (HbA1c) reduction (with a low risk of hypoglycemia) and cardiovascular event prevention. In patients with type 2 diabetes, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Cigrovski Berkovic, Maja, Bilic-Curcic, Ines, Bozek, Tomislav, Herman Mahecic, Davorka, Klobucar Majanovic, Sanja, Canecki-Varzic, Silvija, Andric, Jelena, Marusic, Srecko, Mrzljak, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672794/
https://www.ncbi.nlm.nih.gov/pubmed/33269065
http://dx.doi.org/10.4239/wjd.v11.i11.540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672794/
https://www.ncbi.nlm.nih.gov/pubmed/33269065
http://dx.doi.org/10.4239/wjd.v11.i11.540

Ejemplares similares